Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

✍ Scribed by Gerd Plewig; William J. Cunliffe; Natascha Binder; Kornelia Höschen

• Book ID: 116382175
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 346 KB
• Volume: 80
• Category: Article
• ISSN: 0010-7824
• DOI: 10.1016/j.contraception.2009.02.016